Publications
1. Zhong T, Wu H, Hu J, Liu Y, Zheng Y, Li N, Sun Z, Yin XF, He QY, Sun X. Two synonymous single-nucleotide polymorphisms promoting fluoroquinolone resistance of Escherichia coli in the environment. J Hazard Mater. 2024 May 5;469:133849. doi: 10.1016/j.jhazmat.2024.133849. Epub 2024 Feb 20.(IF=13.6)
2. Hu HF, Gao GB, He X, Li YY, Li YJ, Li B, Pan Y, Wang Y, He QY. Targeting ARF1-IQGAP1 interaction to suppress colorectal cancer metastasis and vemurafenib resistance. J Adv Res. 2023 Sep;51:135-147. doi:10.1016/j.jare. 2022.11.006. (IF=10.7)
3. Wang Y, Chen YY, Gao GB, Zheng YH, Yu NN, Ouyang L, Gao X, Li N, Wen SY, Huang S, Zhao Q, Liu L, Cao M, Zhang S, Zhang J, He QY. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase. Mol Ther. 2023 May 21:S1525-0016(23)00271-X. doi: 10.1016/j.ymthe.2023.05.015. (IF=12.4)
4. Zhang J, Zhou Y, Li N, Liu WT, Liang JZ, Sun Y, Zhang WX, Fang RD, Huang SL, Sun ZH, Wang Y, He QY. “Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2).”Adv Sci. 2020 Oct 15;7(22):2002306. doi: 10.1002/advs.202002306. (IF = 15.1)
5. Xu WW, Huang ZH, Liao L, Zhang QH, Li JQ, Zheng CC, He Y, Luo TT, Wang Y, Hu HF, Zuo Q, Chen WY, Yang QS, Zhao JF, Qin YR, Xu LY, Li EM, Liao HX, Li B, He QY. “Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2-ERK Signaling to Suppress Esophageal Cancer Metastasis.” Adv Sci. 2020 Jul 1;7(16):2000925. doi: 10.1002/advs.202000925. (IF = 15.1)
6. Hu HF, Xu WW, Zhang WX, Yan X, Li YJ, Li B, He QY. “Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance.”Signal Transduct Target Ther. 2020 Nov 27;5(1):271. doi: 10.1038/s41392-020-00275-8. (IF = 39.3)
7. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, Zhou Q, Zeng G, Hu X, Yu L, Zhou S, Tong X, Huang H, Chen H, Liu Q, Liu W, Zhang G, Zeng M, Zhou G, He QY, Ji H, Chen L. “Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.” Nat Commun. 2019 Apr 10;10(1):1665. doi: 10.1038/s41467-019-09295-7. (IF = 16.6)
8. Xu WW, Li B, Guan XY, Chung SK, Wang Y, Yip YL, Law SY, Chan KT, Lee NP, Chan KW, Xu LY, Li EM, Tsao SW, He QY, Cheung AL. “Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.” Nat Commun. 2017 Feb 10;8:14399. doi: 10.1038/ncomms14399. (IF = 16.6)
9. Lu S, Zhang J, Lian X, Sun L, Meng K, Chen Y, Sun Z, Yin X, Li Y, Zhao J, Wang T, Zhang G, He QY. “A hidden human proteome encoded by 'non-coding' genes.” Nucleic Acids Res. 2019 Jul 24. doi: 10.1093/nar/gkz646. (IF = 14.9)
10. Wang T, Cui Y, Jin J, Guo J, Wang G, Yin X, He QY, Zhang G. “Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific.” Nucleic Acids Res. 2013 May;41(9):4743-54. doi: 10.1093/nar/gkt178. (IF = 14.9)
11. Hu HF, Xu WW, Zhang WX, Yan X, Li YJ, Li B, He QY.Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission. Theranostics. 2021 Jan 1;11(4):1828-1844. doi: 10.7150/thno.48698. eCollection 2021.(IF = 12.4)
12. Wang Y, Zhang J, Li YJ, Yu NN, Liu WT, Liang JZ, Xu WW, Sun ZH, Li B, He QY. “MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-kappa B signaling.” J Exp Clin Cancer Res. 2021 Sep 24;40(1):301. doi: 10.1186/s13046-021-02107-1. (IF = 11.3)
13. Zhong Y, Yang J, Xu WW, Wang Y, Zheng CC, Li B, He QY. “KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.” Oncogene. 2017 Nov 2;36(44):6177-6189. doi: 10.1038/onc.2017.287. (IF =8.0)